Alger Health Sciences C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Alger Health Sciences Fund Class C AHSCX
- NAV / 1-Day Return 17.77 / −2.04 %
- Total Assets 86.3M
-
Adj. Expense Ratio
1.960%
- Expense Ratio 1.960%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 289%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 1:46 AM GMT+0
Morningstar’s Analysis AHSCX
Will AHSCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 39.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Cash | 8.11 | 6M | Cash and Equivalents |
Impulse Dynamics | 4.27 | 3M | — |
Merck & Co Inc | 4.17 | 3M | Healthcare |
Welltower Inc | 4.12 | 3M | Real Estate |
Johnson & Johnson | 4.06 | 3M | Healthcare |
Thermo Fisher Scientific Inc | 4.00 | 3M | Healthcare |
Bruker Corp | 3.98 | 3M | Healthcare |
Illumina Inc | 3.95 | 3M | Healthcare |
CVS Health Corp | 3.69 | 3M | Healthcare |
UnitedHealth Group Inc | 3.61 | 3M | Healthcare |
United States